Market Research Logo

Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry


Attention: There is an updated edition available for this report.

Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars of many companies' portfolios. They've also attracted the attention of insurance companies, retail outlets and the media. The global market for vaccines experienced strong growth through 2009 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.

Kalorama Information has been closely following vaccine markets and since 2006 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what’s expected down the road. You can count on the objectivity and accuracy of our numbers and analysis—whether you're preparing a strategic presentation, benchmarking your company's performance against the competition, preparing a new product launch or seeking out an acquisition or a new partnership.

The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.

Included in this report are current market size and forecast for the following vaccines:

  • Pediatric Vaccines:
    • Combinations
    • Hepatitis
    • HIB
    • MMR
    • Pneumococcal
    • Poliovirus
    • Varicella
    • Other Pediatric
  • Adult Vaccines:
    • Cervical Cancer
    • Hepatitis
    • Influenza
    • Pneumococcal
    • Travel; DT; Misc.

Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovations in vaccine Production are covered in the report. In addition, the reort profiles key competitors in the vaccine industry. Companies profiled in the report include:

  • AlphaVax, Inc.
  • Bavarian Nordic A/S
  • Baxter Healthcare
  • Bharat Biotech
  • Celldex Therapeutics
  • Crucell
  • Emergent biosolutions
  • GlaxoSmithKline
  • Medimmune
  • Merck & Co. Inc
  • Nabi Biopharmaceuticals
  • Novartis
  • Pfizer
  • Sanofi Pasteur

Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2009 period and forecasts are provided through 2014. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.


Global Vaccine Market Exceeds $20 Billion: Kalorama

Vaccines continue to be the success story for pharmaceutical companies, with the world market for preventative vaccines totaling $22.1 billion in 2009, up from $19 billion in 2008, according to healthcare market research publisher Kalorama Information. Kalorama’s new report, Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, notes that the worldwide vaccine market is predicted to increase at a compound annual rate of 9.7% during the next five years, as new product introductions continue and the use of current products expands further.

“We’ve forecasted a high growth rate for vaccines over the past few years and market events have matched our predictions,” said Bruce Carlson, publisher of Kalorama Information. “The vaccine business is not without its risks, but for some companies, vaccines were the only bright spot in their portfolio in 2009. It’s not a surprise therefore that development is heavy in this sector, and that will contribute to growth over the next five years.”

Vaccines are commonly segmented into two target markets, adult and pediatric. According to Kalorama Information, the pediatric vaccine market is larger, accounting for more than half of the total market. Pediatric vaccines are also growing at a faster rate than adult vaccines and this is expected to continue over the next five years. Pneumococcal and “combination” DTaP vaccines are driving growth in the pediatric sector, while influenza and hepatitis vaccine products are driving sales in the adult segment of the market. Future growth in adult vaccines will be driven by increased acceptance and new products.

The worldwide vaccine market is dominated by five major competitors: Merck & Co, GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. These companies have made earning a greater share of the vaccine market part of their marketing and research strategies. GlaxoSmithKline is in the lead with nearly a quarter of the world market in 2009, largely due to its influenza products Fluvarix and Hiberix, according to Kalorama.

More information is available from Kalorama Information’s report, Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, including market forecasts, company profiles, and trends in the industry.

  • Executive Summary
    • THE GLOBALVACCINES INDUSTRY
      • Scope and Methodology
      • Overview
      • Pediatric Preventative Vaccines
    • THE MARKET
    • ADULT PREVENTATIVE VACCINES
    • TOTAL MARKET
    • ISSUES AND TRENDS
  • Introduction to Vaccines
    • Table Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2009
    • A BRIEF HISTORY: THE DEVELOPMENT OF VACCINES
    • THE IMMUNE RESPONSE
    • MECHANISM OF ACTION
    • TYPES OF VACCINES
      • Attenuated (Weakened) Live Viruses
        • Table Vaccine-Preventable Diseases, June 2010
      • Killed (Inactivated) Viruses
      • Toxoid Vaccines
      • Genetically Engineered/Modified Vaccines
      • Subunit Vaccines
      • Conjugate Vaccines
      • DNA Vaccination
    • VACCINE APPROVAL PROCESS
      • Table VAERS Table of Reportable Events Following Vaccination
  • Pediatric Preventive Vaccines
    • INTRODUCTION
      • Table Global Immunization Rates by Vaccine Type 2008
    • CHILDHOOD IMMUNIZATION IN THE UNITED STATES
      • Childhood Immunization Rates
        • Table Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2002-2008
      • Challenges to the Vaccine Delivery System
      • The Effect of U.S. Health Care Reform
      • Recommended Childhood Immunization Schedule
        • Table U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2010
        • Table U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2010
      • State Immunization Recommendations
      • United Nations Initiatives
    • PEDIATRIC VACCINE PRODUCTS
      • BCG
      • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
      • Diphtheria
      • Pertussis
      • Tetanus
      • Hepatitis B
      • Poliomyelitis
      • Haemophilus Influenzae Type B
      • Hepatitis A
      • Measles, Mumps and Rubella
      • Measles
      • Mumps
      • Rubella
      • Meningococcal Disease
      • Pneumococcal Conjugate
      • Rotavirus
      • Varicella
    • PEDIATRIC VACCINES IN DEVELOPMENT
      • Table Selected Pediatric Vaccines in Development, June 2010
    • COST OF VACCINES IN THE UNITED STATES
    • THEWORLD MARKET FOR PEDIATRIC PREVENTIVE VACCINES
      • Total Market Size and Forecast
        • Table World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others) 2005-2014 Revenues (in millions)
        • Table World Market for Pediatric Vaccines by Region (U.S., North America, Southmerica, EU, Japan, India, China, Rest of World) 2005-2014 Revenues (in millions)
      • Hepatitis Vaccine Market
        • Table World Pediatric Hepatitis Vaccine Market 2005-2014
      • Haemophilus Influenzae Type B Vaccine Market
        • Table World Hib Vaccine Market, 2005-2014
      • Measles, Mumps and Rubella Vaccines
        • Table World MMR Vaccines Market 2005-2014
      • Combination Vaccines Market
        • Table World Combination Vaccines Market 2005-2014
      • Pneumococcal Vaccine
        • Table World Pediatric Pneumococcal Vaccine Market 2005-2014
      • Poliovirus Vaccine
        • Table World Poliovirus Vaccine Market 2005-2014
      • Varicella Vaccines
        • Table World Varicella Vaccine Market 2005-2014
      • Other Vaccines Market
        • Table World Pediatric Other Vaccines Market 2005-2014
  • Adult Preventive Vaccines
    • INTRODUCTION
    • ADULT VACCINE-PREVENTABLE DISEASES: FACTS AND FIGURES
    • GLOBAL INFLUENZA SURVEILLANCE PROGRAM
    • RECOMMENDATIONS FOR ADULT IMMUNIZATIONS
      • Table Universal Adult Immunization Schedule 2010
      • Table Adult Immunization Schedule for Populations with Special Medical Conditions, 2010
      • WHO International Health Regulations
    • ADULT VACCINE PRODUCTS
      • BCG
      • Cervical Cancer
        • Table Initiatives to Require HPV Vaccination by U.S. State, 2010
      • Cholera
      • Diphtheria-Tetanus
      • Hepatitis
      • Hepatitis A
      • Hepatitis B
      • Influenza
        • Table WHO Pandemic Classification Schedule
      • Japanese Encephalitis
      • Pneumococcal Disease
      • Rabies
      • Shingles
      • Typhoid Fever
      • Yellow Fever
    • ADULT VACCINES IN DEVELOPMENT
      • Table Selected Adult Preventive Vaccines in Development, 2010
    • THEWORLD MARKET FOR ADULT PREVENTIVE VACCINES
      • Total Market Size and Forecast
        • Table World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2005-2014
        • Table World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2005-2014 Revenues (in millions)
      • Cervical Cancer Market
        • Table World Cervical CancerVaccine Market 2005-2014
      • Hepatitis Market
        • Table World Hepatitis Vaccine Market 2005-2014
      • Influenza Vaccine Market
        • Table World Influenza Vaccine Market 2005-2014
        • Table CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs 2010)
        • Table 2009 Estimated Population by Region and Selected Age Group (in millions)
      • Pneumococcal Vaccine Market
        • Table World Pneumococcal Vaccine Market 2005-2014
      • Travel, DT, and Miscellaneous Vaccine Market
        • Table World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2005-2014
  • Vaccines Market Summary
    • TRENDS DRIVING THE VACCINES MARKET
    • MARKET SIZE AND FORECAST
      • Table The World Vaccines Market by Vaccine Type 2005-2014 Revenues (in millions)
      • Vaccine Sales by Region
      • Vaccine Market Competitors
        • Table The World Vaccines Market by Region 2005-2014 Revenues (in millions)
        • Table Major Manufacturers' Shares of the World Vaccine Market, 2009
      • Pediatric Vaccines
        • Table Major Manufacturer's Shares of the World Pediatric Vaccine Market 2009
      • Adult Vaccines
        • Table Major Manufacturer's Shares of the World Adult Vaccine Market 2009
  • Issues and Trends
    • VACCINE SAFETY
      • Refusal to Immunize
      • Obesity
      • Post-Licensure Surveillance
      • Vaccine Adverse Event Reporting System
      • The Vaccine Safety Datalink Project
      • Phase IV studies
      • The Vaccine Injury Compensation Program
      • Countermeasures Injury Compensation Program
      • World Health Organization
      • Other Initiatives
      • The Future of Vaccine Safety
    • VACCINE SHORTAGES
      • Preventing Shortages in the Developed Countries
      • Financial incentives
      • Equitable pricing
      • Vaccine stockpiles
      • Preventing Shortages in Developing Nations
      • Vaccine bonds
    • PREVENTING PANDEMICS
      • U.S. National Vaccine Plan
    • VACCINES AND BIOTERRORISM
      • Overview
      • Project Bioshield Act
        • Table Selected Companies/Laboratories Developing Biodefense Vaccines
      • National Bio and Agro-Defense Facility
      • Vaccine Treatment and Evaluation Units
      • Anthrax
      • Smallpox
      • Tularemia
      • Viral Hemorrhagic Fevers
    • DNAVACCINATION
    • INNOVATIONS IN VACCINE DELIVERY SYSTEMS
      • Edible Vaccines
      • Mucosal Delivery
      • Intranasal Delivery
      • Vaccine Patches
      • Vaccine Chips
    • INNOVATIONS IN VACCINE PRODUCTION
      • Tobacco Plants
      • Insects
      • Nanoparticle Systems
  • Company Profiles
    • ALPHAVAX, INC.
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BAVARIAN NORDIC A/S
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BAXTER HEALTHCARE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BHARAT BIOTECH
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • CELLDEX THERAPEUTICS
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • CRUCELL
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • EMERGENT BIOSOLUTIONS
      • History and Lines of Business
      • Strategic Acquisition and Alliance
      • Vaccine Products
      • Financial
    • GLAXOSMITHKLINE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • MEDIMMUNE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • MERCK&CO. INC
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • NABI BIOPHARMACEUTICALS
      • History and Lines of Business
      • Strategic Alliance
      • Vaccine Products
      • Financial Information
    • NOVARTIS
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • PFIZER
      • History and Lines of Business
      • Strategic alliances
      • Vaccine Products
      • Financial Information
    • SANOFI PASTEUR
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report